1. Home
  2. TNXP vs SPIR Comparison

TNXP vs SPIR Comparison

Compare TNXP & SPIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • SPIR
  • Stock Information
  • Founded
  • TNXP 2007
  • SPIR 2012
  • Country
  • TNXP United States
  • SPIR United States
  • Employees
  • TNXP N/A
  • SPIR N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • SPIR Telecommunications Equipment
  • Sector
  • TNXP Health Care
  • SPIR Consumer Discretionary
  • Exchange
  • TNXP Nasdaq
  • SPIR Nasdaq
  • Market Cap
  • TNXP 272.0M
  • SPIR 251.8M
  • IPO Year
  • TNXP N/A
  • SPIR N/A
  • Fundamental
  • Price
  • TNXP $35.48
  • SPIR $11.92
  • Analyst Decision
  • TNXP Strong Buy
  • SPIR Strong Buy
  • Analyst Count
  • TNXP 2
  • SPIR 5
  • Target Price
  • TNXP $585.00
  • SPIR $16.75
  • AVG Volume (30 Days)
  • TNXP 729.5K
  • SPIR 716.2K
  • Earning Date
  • TNXP 08-15-2025
  • SPIR 08-13-2025
  • Dividend Yield
  • TNXP N/A
  • SPIR N/A
  • EPS Growth
  • TNXP N/A
  • SPIR N/A
  • EPS
  • TNXP N/A
  • SPIR N/A
  • Revenue
  • TNXP $10,041,000.00
  • SPIR $99,502,000.00
  • Revenue This Year
  • TNXP $11.66
  • SPIR N/A
  • Revenue Next Year
  • TNXP $793.18
  • SPIR $7.37
  • P/E Ratio
  • TNXP N/A
  • SPIR N/A
  • Revenue Growth
  • TNXP N/A
  • SPIR N/A
  • 52 Week Low
  • TNXP $6.76
  • SPIR $6.26
  • 52 Week High
  • TNXP $130.00
  • SPIR $21.43
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 52.96
  • SPIR 59.56
  • Support Level
  • TNXP $33.71
  • SPIR $11.10
  • Resistance Level
  • TNXP $38.13
  • SPIR $12.25
  • Average True Range (ATR)
  • TNXP 2.62
  • SPIR 0.66
  • MACD
  • TNXP -0.44
  • SPIR 0.11
  • Stochastic Oscillator
  • TNXP 61.01
  • SPIR 89.04

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About SPIR Spire Global Inc.

Spire Global Inc is a provider of space-based data, analytics, and Space Services, offering datasets and powerful insights about Earth from the ultimate vantage point of space so that organizations can make decisions with confidence, accuracy, and speed. It generates revenue from four solutions: Maritime, Aviation, Weather, and Space Services. It offers the following three data solutions to customers; Maritime-precise space-based data used for accurate ship monitoring, ship safety, and route optimization, Aviation-precise space-based data used for accurate aircraft monitoring, aircraft safety, and route optimization, and Weather-precise space-based data used for accurate weather forecasting.

Share on Social Networks: